Literature DB >> 33008831

Ion Channels and Their Role in the Pathophysiology of Gliomas.

Takeshi Takayasu1,2, Kaoru Kurisu2, Yoshua Esquenazi3,4, Leomar Y Ballester5,6,4.   

Abstract

Malignant gliomas are the most common primary central nervous system tumors and their prognosis is very poor. In recent years, ion channels have been demonstrated to play important roles in tumor pathophysiology such as regulation of gene expression, cell migration, and cell proliferation. In this review, we summarize the current knowledge on the role of ion channels on the development and progression of gliomas. Cell volume changes through the regulation of ion flux, accompanied by water flux, are essential for migration and invasion. Signaling pathways affected by ion channel activity play roles in cell survival and cell proliferation. Moreover, ion channels are involved in glioma-related seizures, sensitivity to chemotherapy, and tumor metabolism. Ion channels are potential targets for the treatment of these lethal tumors. Despite our increased understanding of the contributions of ion channels to glioma biology, this field remains poorly studied. This review summarizes the current literature on this important topic. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33008831      PMCID: PMC7577395          DOI: 10.1158/1535-7163.MCT-19-0929

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  84 in total

1.  Prognostic value of ion channel genes in Chinese patients with gliomas based on mRNA expression profiling.

Authors:  Feng-Fei Lu; Hao-Yuan Wang; Xiao-Zheng He; Ting-Yu Liang; Wen Wang; Hui-Min Hu; Fan Wu; Yan-Wei Liu; Shi-Zhong Zhang
Journal:  J Neurooncol       Date:  2017-07-27       Impact factor: 4.130

2.  Chemical structure and properties of midazolam compared with other benzodiazepines.

Authors:  M Gerecke
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

3.  Double Blockade of Glioma Cell Proliferation and Migration by Temozolomide Conjugated with NPPB, a Chloride Channel Blocker.

Authors:  Miri Park; Chiman Song; Hojong Yoon; Kee-Hyun Choi
Journal:  ACS Chem Neurosci       Date:  2016-01-08       Impact factor: 4.418

4.  MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-à-go-go (EAG1).

Authors:  Yifeng Bai; Hongzhan Liao; Tianzhu Liu; Xiangping Zeng; Faman Xiao; Luqiao Luo; Hongbo Guo; Linlang Guo
Journal:  Eur J Cancer       Date:  2012-09-18       Impact factor: 9.162

5.  Invasion of human glioma cells is regulated by multiple chloride channels including ClC-3.

Authors:  Vincent Chi Hang Lui; Steven Sin Sai Lung; Jenny Kan Suen Pu; Kwan Ngai Hung; Gilberto Kat Kit Leung
Journal:  Anticancer Res       Date:  2010-11       Impact factor: 2.480

6.  Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.

Authors:  Matthias Holdhoff; Xiaobu Ye; Jeffrey G Supko; Louis B Nabors; Arati S Desai; Tobias Walbert; Glenn J Lesser; William L Read; Frank S Lieberman; Martin A Lodge; Jeffrey Leal; Joy D Fisher; Serena Desideri; Stuart A Grossman; Richard L Wahl; David Schiff
Journal:  Neuro Oncol       Date:  2017-06-01       Impact factor: 12.300

7.  Targetable T-type Calcium Channels Drive Glioblastoma.

Authors:  Ying Zhang; Nichola Cruickshanks; Fang Yuan; Baomin Wang; Mary Pahuski; Julia Wulfkuhle; Isela Gallagher; Alexander F Koeppel; Sarah Hatef; Christopher Papanicolas; Jeongwu Lee; Eli E Bar; David Schiff; Stephen D Turner; Emanuel F Petricoin; Lloyd S Gray; Roger Abounader
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

8.  Effect of pannexin-1 on the release of glutamate and cytokines in astrocytes.

Authors:  Li Wei; Hanmiao Sheng; Long Chen; Bin Hao; Xiaohong Shi; Yinghui Chen
Journal:  J Clin Neurosci       Date:  2015-09-16       Impact factor: 1.961

9.  Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy.

Authors:  Julia Pollak; Karan G Rai; Cory C Funk; Sonali Arora; Eunjee Lee; Jun Zhu; Nathan D Price; Patrick J Paddison; Jan-Marino Ramirez; Robert C Rostomily
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

10.  NKCC1 Regulates Migration Ability of Glioblastoma Cells by Modulation of Actin Dynamics and Interacting with Cofilin.

Authors:  Paula Schiapparelli; Hugo Guerrero-Cazares; Roxana Magaña-Maldonado; Susan M Hamilla; Sara Ganaha; Eric Goulin Lippi Fernandes; Chuan-Hsiang Huang; Helim Aranda-Espinoza; Peter Devreotes; Alfredo Quinones-Hinojosa
Journal:  EBioMedicine       Date:  2017-06-21       Impact factor: 8.143

View more
  6 in total

1.  Expression changes in ion channel and immunity genes are associated with glioma-related epilepsy in patients with diffuse gliomas.

Authors:  Lianwang Li; Chuanbao Zhang; Zheng Wang; Yuhao Guo; Yinyan Wang; Xing Fan; Tao Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-18       Impact factor: 4.322

Review 2.  Ion Channel Involvement in Tumor Drug Resistance.

Authors:  Concetta Altamura; Paola Gavazzo; Michael Pusch; Jean-François Desaphy
Journal:  J Pers Med       Date:  2022-02-03

3.  The function of Piezo1 in hepatoblastoma metastasis and its potential transduction mechanism.

Authors:  Xiaoshuo Ye; Yongjie Xia; Yuelan Zheng; Wei Chen; Zimin Chen; Zhen Cheng; Bin Wang
Journal:  Heliyon       Date:  2022-08-19

Review 4.  Glioma‑neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives (Review).

Authors:  Tianzhen Hua; Huanxiao Shi; Mengmei Zhu; Chao Chen; Yandong Su; Shengjia Wen; Xu Zhang; Juxiang Chen; Qilin Huang; Hongxiang Wang
Journal:  Int J Oncol       Date:  2022-07-20       Impact factor: 5.884

Review 5.  Cancer as a Channelopathy-Appreciation of Complimentary Pathways Provides a Different Perspective for Developing Treatments.

Authors:  Harry J Gould; Dennis Paul
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

6.  LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma Cells.

Authors:  Concetta Caglioti; Federico Palazzetti; Lorenzo Monarca; Raffaele Lobello; Maria Rachele Ceccarini; Rossana Giulietta Iannitti; Roberta Russo; Francesco Ragonese; Chiara Pennetta; Antonella De Luca; Michela Codini; Bernard Fioretti
Journal:  Front Physiol       Date:  2022-01-07       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.